Quick Answer
Evommune, Inc. reported Earnings Per Share Diluted of $11.22 (loss) per share for the year ending 2025.
- Evommune, Inc. showed an increase of +75.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Evommune, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2024: $10.47 (loss) per share | Q3 2025: $8.07 (loss) per share.
- Historical annual values: Fiscal year 2025: $11.22 (loss) per share | Fiscal year 2024: $45.29 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: